SKOKIE, Ill., Nov. 19, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ:LNZA) ("LanzaTech" or the "Company"), a carbon management solutions company, today reported its financial and operating results for the third quarter ended September 30, 2025.
Key Highlights:
- First Commercial Ethanol-to-Jet Plant Operational: In November 2025, LanzaJet, Inc., a sustainable aviation fuel ("SAF") joint venture entity in which the Company has a 36.33% equity interest, began fully operating and producing fuels at its LanzaJet Freedom Pines Fuels facility in Soperton, Georgia, USA – marking both the world's first production at a commercial-scale plant of jet fuel using ethanol as a feedstock, and the first renewable solution, compatible with today's aircraft, that does not rely on lipids or oils.
- EU Innovation Fund: In November 2025, LanzaTech was awarded a €40 million grant from the European Union's Innovation Fund, subject to the finalization of the grant agreement expected in the spring of 2026. The project, an integrated CCUS facility in Norway, will feature the first commercial deployment of LanzaTech's second-generation bioreactor and aims to produce 23.5 kt (~8M U.S. gallons) of ethanol per year by consuming ferroalloy emissions.
Third Quarter 2025 Financial Results
The table below outlines key results for the three and nine months ended September 30, 2025 and 2024, respectively:
| All amounts in millions ($) | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenue | $ | 9.3 | $ | 9.9 | $ | 27.8 | $ | 37.6 | |||||||
| Cost of revenue(1) | 6.9 | 8.1 | 20.7 | 20.4 | |||||||||||
| Operating expenses | 18.0 | 34.8 | 86.1 | 99.1 | |||||||||||
| Net income (loss) | 2.9 | (57.4 | ) | (48.9 | ) | (110.7 | ) | ||||||||
| Adjusted EBITDA loss(2) | $ | (13.5 | ) | $ | (27.1 | ) | $ | (73.7 | ) | $ | (67.0 | ) | |||
(1) Exclusive of depreciation.
(2) See "Non-GAAP Financial Measures" and "Reconciliations of GAAP Net Loss to Adjusted EBITDA" sections herein for an explanation and reconciliations of non-GAAP measures used throughout this release.
Revenue
- Reported total revenue of $9.3 million in the third quarter of 2025, compared to $9.9 million in the third quarter of 2024. The year-over-year decrease was due to reductions in Joint Development Agreements("JDA") business and a decline in engineering and other services and activity, partially offset by growth from CarbonSmart™ revenue:
- Engineering and other services revenue in the third quarter of 2025 was $4.0 million, compared to $4.9 million in the third quarter of 2024, due to the completion of projects with existing customers and government entities.
- JDA and contract research revenue was $1.2 million in the third quarter of 2025, compared to $1.8 million in the third quarter of 2024, due to the completion of projects with existing customers and the absence of new contracts as a result of workforce reductions.
- CarbonSmart revenue was $3.0 million in the third quarter of 2025, compared to $2.2 million in the third quarter of 2024. The increase was due to an increased sales volume in CarbonSmart products during the three months ended September 30, 2025 compared to the same period last year.
- Engineering and other services revenue in the third quarter of 2025 was $4.0 million, compared to $4.9 million in the third quarter of 2024, due to the completion of projects with existing customers and government entities.
Cost of Revenue
- Cost of revenue decreased by $1.2 million, or 15%, in the three months ended September 30, 2025, compared to the same period in 2024. The year-over-year decrease was primarily driven by a $1.2 million reduction in engineering and other service costs associated with the completion of projects for existing customers and government entities, as well as a change in revenue mix related to the increase in CarbonSmart sales, a lower margin business as compared to biorefining and JDA revenues.
Operating Expense
- Operating expenses were $18.0 million in the third quarter of 2025, compared to $34.8 million in the third quarter of 2024. The year-over-year decrease was primarily due to a $3.0 million decrease in personnel and contractor expenses related to R&D projects, reflecting headcount reductions implemented during the third quarter of 2025 as part of the Company's broader cost optimization initiatives.
Net Income
- Net Income for the third quarter of 2025 was $2.9 million, compared to a $57.4 million net loss in the same period last year. Net income increased year-over-year primarily as a result of a $38.1 million non-cash gain on financial instruments recognized in the third quarter of 2025. In addition, the operating expenses decreased by $16.5 million during the third quarter of 2025 compared to the same period last year, due to headcount reductions implemented as part of the Company's broader cost optimization initiative.
Adjusted EBITDA Loss
- Adjusted EBITDA loss was $13.5 million in the third quarter of 2025, compared to $27.1 million in the same period last year. The decrease in Adjusted EBITDA loss year-over-year was primarily attributable to lower selling, general and administrative expenses as a result of cost optimization efforts, along with lower revenue and higher cost of sales period-over-period. While expected to reduce long-term expenses, short-term restructuring costs were impacted during the quarter ended September 30, 2025.
Balance Sheet and Liquidity
- As of September 30, 2025, the Company had $23.5 million in total cash, restricted cash, and investments, compared to total cash of $39.6 million as of June 30, 2025. The decrease reflects continued use of cash to fund operating activities, timing of receipts from customers and government projects, and limited inflows from new funding sources.
Management Comments
"This has been a year of disciplined transformation. By aligning our structure to the realities of the market and focusing on the highest-value paths—especially the growing demand for SAF—we believe that we've strengthened our position and regained momentum, said Dr. Jennifer Holmgren, Board Chair and CEO of LanzaTech. "SAF is a practical and important outlet for the ethanol we produce, and we believe we've adjusted the business so we can focus on that opportunity more directly, provided we obtain the necessary capital to do so."
About LanzaTech
LanzaTech (NASDAQ:LNZA) is a leader in carbon management, using its proprietary gas-fermentation platform to transform waste carbon into valuable products. Through global partnerships, LanzaTech enables the production of feedstocks for high-value markets including SAF and chemicals. Headquartered in the U.S., the company provides technology and commercial pathways that strengthen industrial resilience and unlock new economic value from carbon.
Forward-Looking Statements
This press release includes forward-looking statements regarding, among other things, the plans, strategies and prospects, both business and financial, of the Company. These statements are based on the beliefs and assumptions of the Company's management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Generally, statements that are not historical facts, including statements concerning possible or assumed future actions, business strategies, events or results of operations, are forward-looking statements. These statements may be preceded by, followed by or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "will," "should," "seeks," "plans," "scheduled," "anticipates," "intends" or similar expressions. The forward-looking statements are based on projections prepared by, and are the responsibility of, the Company's management. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements, including the Company's ability to continue to operate as a going concern; the Company's ability to consummate the transactions contemplated by the Series A Convertible Senior Preferred Stock Purchase Agreement, dated May 7, 2025, as amended; delays or interruptions in government contract awards, funding cycles or agency operations (including due to a government shutdown) that could postpone project milestones and defer related revenue recognition; the Company's ability to attract new investors and raise substantial additional financing to fund its operations and/or execute on its other strategic options; the Company's ability to maintain the listing of the Nasdaq Stock Market LLC; the Company's ability to execute on its business strategy and achieve profitability; and the Company's ability to attract, reatin and motivate qualified personnel. The Company may be adversely affected by other economic, business, or competitive factors, and other risks and uncertainties, including those described under the header "Risk Factors" in its Form 10-K for the year ended December 31, 2024, its Form 10-Q for the quarter ended March 31, 2025, June 30, 2025 and September 30, 2025 and in future SEC filings. New risk factors that may affect actual results or outcomes emerge from time to time and it is not possible to predict all such risk factors, nor can the Company assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. The Company undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP Financial Measures
To supplement our financial statements presented in accordance with GAAP and to provide investors with additional information regarding our financial results, we have presented Adjusted EBITDA, a non-GAAP financial measure. Adjusted EBITDA is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to similarly titled measures presented by other companies.
We define Adjusted EBITDA as our net loss, excluding the impact of depreciation, interest income, net, stock-based compensation expense, change in fair value of warrant liabilities, loss on the Brookfield SAFE extinguishment, change in fair value of the Brookfield SAFE and the Brookfield Loan liabilities (net of interest accretion reversal), change in fair value of the FPA Put Option liability and Fixed Maturity Consideration, change in fair value of the Convertible Note, change in fair value of the PIPE Warrant and loss from equity method investees, net. We monitor and have presented in this earnings press release Adjusted EBITDA because it is a key measure used by our management and the Board to understand and evaluate our operating performance, to establish budgets, and to develop operational goals for managing our business. We believe Adjusted EBITDA helps identify underlying trends in our business that could otherwise be masked by the effect of certain expenses that we include in net loss. Accordingly, we believe Adjusted EBITDA provides useful information to investors, analysts, and others in understanding and evaluating our operating results and enhancing the overall understanding of our past performance and future prospects.
Adjusted EBITDA is not prepared in accordance with GAAP and should not be considered in isolation of, or as an alternative to, measures prepared in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA rather than net loss, which is the most directly comparable financial measure calculated and presented in accordance with GAAP. For example, Adjusted EBITDA: (i) excludes stock-based compensation expense because it is a significant non-cash expense that is not directly related to our operating performance; (ii) excludes depreciation expense and, although this is a non-cash expense, the assets being depreciated and amortized may have to be replaced in the future; (iii) excludes gain or losses on equity method investee; and (iv) excludes certain income or expense items that do not provide a comparable measure of our business performance. In addition, the expenses and other items that we exclude in our calculations of Adjusted EBITDA may differ from the expenses and other items, if any, that other companies may exclude from Adjusted EBITDA when they report their operating results. In addition, other companies may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison.
| LANZATECH GLOBAL INC. CONSOLIDATED BALANCE SHEETS | |||||||
| (Unaudited, in thousands, except share and per share data) | |||||||
| September 30, | December 31, | ||||||
| 2025 | 2024 | ||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 19,627 | $ | 43,499 | |||
| Held-to-maturity investment securities | — | 12,374 | |||||
| Trade and other receivables, net of allowance | 8,700 | 9,456 | |||||
| Contract assets | 9,342 | 18,975 | |||||
| Other current assets | 12,960 | 15,030 | |||||
| Total current assets | 50,629 | 99,334 | |||||
| Property, plant and equipment, net | 18,293 | 22,333 | |||||
| Right-of-use assets | 14,548 | 26,790 | |||||
| Equity method investment | — | 4,363 | |||||
| Equity security investment | 14,990 | 14,990 | |||||
| Other non-current assets | 830 | 6,873 | |||||
| Total assets | $ | 99,290 | $ | 174,683 | |||
| Liabilities, Mezzanine Equity and Shareholders' Equity/(Deficit) | |||||||
| Current liabilities: | |||||||
| Accounts payable | 6,202 | 5,289 | |||||
| Other accrued liabilities | 10,384 | 8,876 | |||||
| Warrants | 43 | 3,531 | |||||
| Fixed Maturity Consideration and current FPA Put Option liability | 4,123 | 4,123 | |||||
| Contract liabilities | 2,042 | 6,168 | |||||
| Accrued salaries and wages | 1,873 | 2,302 | |||||
| Current lease liabilities | 169 | 158 | |||||
| Total current liabilities | 24,836 | 30,447 | |||||
| Non-current lease liabilities | 16,532 | 30,619 | |||||
| Non-current contract liabilities | 5,901 | 5,233 | |||||
| FPA Put Option liability | 30,015 | 30,015 | |||||
| Brookfield SAFE liability | — | 13,223 | |||||
| Brookfield Loan liability | 13,300 | — | |||||
| Convertible Note | — | 51,112 | |||||
| Other long-term liabilities | 514 | 587 | |||||
| Total liabilities | 91,098 | 161,236 | |||||
| Mezzanine Equity | |||||||
| Convertible preferred stock, $0.0001 par value; 20,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 20,000,000 and no shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | 2 | — | |||||
| Preferred stock - additional paid-in capital | 13,167 | — | |||||
| Total mezzanine equity | 13,169 | — | |||||
| Shareholders' Equity/(Deficit) | |||||||
| Common stock, $0.0000001 par value, 25,800,000 shares authorized as of September 30, 2025 and December 31, 2024; 2,319,960 and 1,949,157 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively (1) | 23 | 19 | |||||
| Additional paid-in capital | 1,011,901 | 981,638 | |||||
| Accumulated other comprehensive income | 1,568 | 1,393 | |||||
| Accumulated deficit | (1,018,470 | ) | (969,603 | ) | |||
| Total shareholders' equity/(deficit) | (4,978 | ) | 13,447 | ||||
| Total liabilities, mezzanine equity and shareholders' equity/(deficit) | 99,289 | 174,683 | |||||
(1) All common stock share and per share data for all periods presented have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company's common stock and the decrease in the par value of the Company's common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025.
| LANZATECH GLOBAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | |||||||||||||||
| (Unaudited, in thousands, except share and per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Revenues: | |||||||||||||||
| Contracts with customers and grants | $ | 5,047 | $ | 5,199 | $ | 10,870 | $ | 17,684 | |||||||
| CarbonSmart product sales | 2,972 | 2,209 | 10,994 | 4,010 | |||||||||||
| Collaborative arrangements | 62 | 917 | 2,425 | 4,469 | |||||||||||
| Related party transactions | 1,198 | 1,618 | 3,557 | 11,399 | |||||||||||
| Total revenues | 9,279 | 9,943 | 27,846 | 37,562 | |||||||||||
| Costs and operating expenses: | |||||||||||||||
| Contracts with customers and grants(1) | 3,812 | 5,339 | 8,908 | 14,356 | |||||||||||
| CarbonSmart product sales(1) | 3,001 | 2,116 | 10,869 | 3,649 | |||||||||||
| Collaborative arrangements(1) | 78 | 479 | 822 | 2,034 | |||||||||||
| Related party transactions(1) | 25 | 207 | 60 | 363 | |||||||||||
| Research and development expense | 10,255 | 22,006 | 41,684 | 60,548 | |||||||||||
| Depreciation expense | 1,025 | 1,301 | 2,860 | 4,289 | |||||||||||
| Selling, general and administrative expense | 6,740 | 11,452 | 41,594 | 34,236 | |||||||||||
| Total cost and operating expenses | 24,936 | 42,900 | 106,797 | 119,475 | |||||||||||
| Loss from operations | (15,657 | ) | (32,957 | ) | (78,951 | ) | (81,913 | ) | |||||||
| Other income (expense): | |||||||||||||||
| Interest income, net | 311 | 791 | 941 | 2,452 | |||||||||||
| Other income (expense), net | 18,359 | (19,730 | ) | 39,162 | (23,342 | ) | |||||||||
| Total other income (expense), net | 18,670 | (18,939 | ) | 40,103 | (20,890 | ) | |||||||||
| Loss from equity method investees, net | (152 | ) | (5,535 | ) | (10,019 | ) | (7,935 | ) | |||||||
| Net income (loss) | $ | 2,861 | $ | (57,431 | ) | $ | (48,867 | ) | $ | (110,738 | ) | ||||
| Other comprehensive loss: | |||||||||||||||
| Changes in credit risk of fair value instruments | — | — | 1,091 | — | |||||||||||
| Foreign currency translation adjustments | (162 | ) | (48 | ) | (916 | ) | (198 | ) | |||||||
| Comprehensive income (loss) | $ | 2,699 | $ | (57,479 | ) | $ | (48,692 | ) | $ | (110,936 | ) | ||||
| Net income (loss) per common share - basic | $ | 1.14 | $ | (29.04 | ) | $ | (22.66 | ) | $ | (56.07 | ) | ||||
| Net income (loss) per common share - diluted | $ | 0.99 | $ | (29.04 | ) | $ | (22.66 | ) | $ | (56.07 | ) | ||||
| Weighted-average number of common shares outstanding - basic(2) | 2,320,018 | 1,977,734 | 2,156,721 | 1,974,992 | |||||||||||
| Weighted-average number of common shares outstanding - diluted(2) | 2,663,193 | 1,977,734 | 2,156,721 | 1,974,992 | |||||||||||
(1) exclusive of depreciation
(2) All common stock share and per share data for all periods presented have been retroactively adjusted to reflect the 1-for-100 reverse stock split of the Company's common stock and the decrease in the par value of the Company's common stock from $0.0001 to $0.0000001 per share which became effective on August 18, 2025.
| LANZATECH GLOBAL, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) | |||||||
| September 30, | |||||||
| 2025 | 2024 | ||||||
| Cash Flows From Operating Activities: | |||||||
| Net loss | $ | (48,867 | ) | $ | (110,738 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Share-based compensation expense | 5,913 | 9,739 | |||||
| Gain on change in fair value of SAFE and warrant liabilities | (3,437 | ) | (20,609 | ) | |||
| Loss on change in fair value of the Brookfield Loan | 5,310 | — | |||||
| Loss on change in fair value of the Amended Brookfield Loan | 1,000 | — | |||||
| Loss on Brookfield SAFE extinguishment | 6,216 | — | |||||
| Loss on change in fair value of the FPA Put Option and current FPA Put Option liability | — | 23,511 | |||||
| Change in fair value of Convertible Note | (42,980 | ) | 21,572 | ||||
| Gain on change in fair value of PIPE Warrant liability | (8,800 | ) | — | ||||
| Gain on partial lease termination | (60 | ) | — | ||||
| Provisions for losses on trade and other receivables, net of recoveries | 126 | (700 | ) | ||||
| Depreciation of property, plant and equipment | 2,860 | 4,289 | |||||
| Amortization of discount on debt security investment | (34 | ) | (649 | ) | |||
| Non-cash lease expense | 1,383 | 1,411 | |||||
| Non-cash recognition of licensing revenue | (3,613 | ) | (10,385 | ) | |||
| Loss from equity method investees, net | 10,019 | 7,935 | |||||
| Unrealized Loss on net foreign exchange | 546 | 1,060 | |||||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable, net | 713 | (2,902 | ) | ||||
| Contract assets | 9,870 | 9,269 | |||||
| Accrued interest on debt investment | (83 | ) | 131 | ||||
| Other assets | 3,731 | (2,156 | ) | ||||
| Accounts payable and accrued salaries and wages | 537 | 409 | |||||
| Contract liabilities | (104 | ) | 564 | ||||
| Operating lease liabilities | (991 | ) | 13 | ||||
| Other liabilities | 2,053 | (1,148 | ) | ||||
| Net cash used in operating activities | (58,692 | ) | (69,384 | ) | |||
| Cash Flows From Investing Activities: | |||||||
| Purchase of property, plant and equipment | (1,047 | ) | (3,557 | ) | |||
| Purchase of debt securities | — | (27,083 | ) | ||||
| Proceeds from maturity of debt securities | 12,408 | 44,770 | |||||
| Net cash provided by investing activities | 11,361 | 14,130 | |||||
| Cash Flows From Financing Activities: | |||||||
| Proceeds from issuance of preferred stock | 15,050 | — | |||||
| Issuance costs related to preferred stock | (1,881 | ) | — | ||||
| Proceeds from issue of equity instruments of the Company | — | 272 | |||||
| Proceeds from issuance of Convertible Note, net | — | 40,000 | |||||
| Repurchase of equity instruments of the Company | — | (48 | ) | ||||
| Partial settlement of the Brookfield Loan | (12,500 | ) | — | ||||
| Proceeds from PIPE Warrant | 24,950 | — | |||||
| Net cash provided by financing activities | 25,619 | 40,224 | |||||
| Effects of currency translation on cash, cash equivalents and restricted cash | (523 | ) | (287 | ) | |||
| Net decrease in cash, cash equivalents and restricted cash | (22,235 | ) | (15,317 | ) | |||
| Cash, cash equivalents and restricted cash at beginning of period | 45,737 | 76,284 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 23,502 | $ | 60,967 | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||
| Acquisition of property, plant and equipment under accounts payable | 79 | 40 | |||||
| Right-of-use asset additions | — | 9,014 | |||||
| Extinguishment of the Brookfield SAFE | 13,274 | — | |||||
| Issuance of the Brookfield Loan | (19,490 | ) | — | ||||
| Extinguishment of the Amended Brookfield Loan | 12,300 | — | |||||
| Issuance of the Amended Brookfield Loan | (12,300 | ) | — | ||||
| Cashless issuance of equity for Convertible Notes | 8,132 | — | |||||
| Non-cash change in lease liability on partial termination | 13,025 | — | |||||
| Non-cash change in ROU assets on partial termination | (13,085 | ) | — | ||||
| LANZATECH GLOBAL INC Reconciliation of Net Loss to Adjusted EBITDA (Unaudited, in thousands) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net income (loss) | $ | 2,861 | $ | (57,431 | ) | $ | (48,867 | ) | $ | (110,738 | ) | ||||
| Depreciation | 1,025 | 1,301 | 2,860 | 4,289 | |||||||||||
| Interest income, net | (311 | ) | (791 | ) | (941 | ) | (2,452 | ) | |||||||
| Stock-based compensation expense and change in fair value of Brookfield SAFE and warrant liabilities(1) | 1,104 | 3,221 | 2,476 | (10,870 | ) | ||||||||||
| Loss on Brookfield SAFE extinguishment | — | — | 6,216 | — | |||||||||||
| Change in fair value of the FPA Put Option and Fixed Maturity Consideration liabilities (net of interest accretion reversal) | — | (488 | ) | — | 23,283 | ||||||||||
| Change in fair value of Convertible Note | — | 21,572 | (42,980 | ) | 21,572 | ||||||||||
| Change in fair value of PIPE Warrant | (12,200 | ) | — | (8,800 | ) | — | |||||||||
| Change in fair value of the Brookfield Loan | (7,135 | ) | — | 5,310 | — | ||||||||||
| Change in fair value of the Amended Brookfield Loan | 1,000 | — | 1,000 | — | |||||||||||
| Loss from equity method investees, net | 152 | 5,535 | 10,019 | 7,935 | |||||||||||
| Adjusted EBITDA | $ | (13,504 | ) | $ | (27,081 | ) | $ | (73,707 | ) | $ | (66,981 | ) | |||
(1) Stock-based compensation expense represents expense related to equity compensation plans.
Investor Relations Contact:
[email protected]
Public Relations/Media Contact:
Freya Burton
[email protected]
